Waverton Investment Management Ltd Acquires 29,897 Shares of GE HealthCare Technologies Inc. $GEHC

Waverton Investment Management Ltd lifted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,086,668 shares of the company’s stock after buying an additional 29,897 shares during the period. GE HealthCare Technologies comprises 1.0% of Waverton Investment Management Ltd’s holdings, making the stock its 24th largest position. Waverton Investment Management Ltd owned approximately 0.24% of GE HealthCare Technologies worth $81,582,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. London & Capital Asset Management Ltd boosted its position in GE HealthCare Technologies by 102.1% during the third quarter. London & Capital Asset Management Ltd now owns 38,271 shares of the company’s stock valued at $2,874,000 after purchasing an additional 19,337 shares during the last quarter. Arete Wealth Advisors LLC grew its stake in shares of GE HealthCare Technologies by 1.8% in the third quarter. Arete Wealth Advisors LLC now owns 9,785 shares of the company’s stock valued at $735,000 after buying an additional 173 shares in the last quarter. APG Asset Management N.V. increased its holdings in GE HealthCare Technologies by 2.1% during the third quarter. APG Asset Management N.V. now owns 279,802 shares of the company’s stock worth $21,013,000 after buying an additional 5,818 shares during the last quarter. American Century Companies Inc. raised its position in GE HealthCare Technologies by 22.6% during the third quarter. American Century Companies Inc. now owns 3,009,077 shares of the company’s stock worth $225,982,000 after acquiring an additional 555,568 shares in the last quarter. Finally, Integrated Advisors Network LLC raised its position in GE HealthCare Technologies by 17.4% during the third quarter. Integrated Advisors Network LLC now owns 3,216 shares of the company’s stock worth $242,000 after acquiring an additional 476 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 0.4%

GEHC stock opened at $84.27 on Monday. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $90.26. The company has a market capitalization of $38.41 billion, a PE ratio of 18.48, a price-to-earnings-growth ratio of 1.85 and a beta of 1.03. The company’s 50-day simple moving average is $82.38 and its 200 day simple moving average is $78.46. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. The firm had revenue of $5.70 billion for the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The company’s revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the company earned $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s payout ratio is currently 3.07%.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Piper Sandler lifted their price target on GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an “overweight” rating in a report on Friday, January 30th. Morgan Stanley raised their price objective on GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 4th. Wells Fargo & Company lifted their target price on GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday, December 29th. Finally, Evercore lifted their price objective on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Seven research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Hold” and an average target price of $92.50.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.